[Long-term results of percutaneous mitral valvuloplasty in patients over 50 years old]

Raúl Astudillo1, José Antonio Palomo Villada, Jaime Santiago

  • 1Cardiólogo del Servicio de Hemodinamia, Hospital de Cardiologia del Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social.

Abstract

Insights

Percutaneous Mitral Valvulotomy (PMV) in patients over 50 is safe and effective, with high immediate success. Long-term follow-up shows a 19% restenosis rate, indicating a need for ongoing monitoring.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Valvular Heart Disease

Context:

  • Advanced age is linked to complications in Percutaneous Mitral Valvulotomy (PMV).
  • The specific contributions of age versus valvular anatomy to outcomes require clarification.
  • Rheumatic mitral stenosis necessitates effective treatment strategies.

Purpose:

  • To evaluate the immediate and long-term outcomes of PMV using the Inoue balloon in patients aged over 50.
  • To correlate complications with patient age and the Wilkins score.
  • To assess the efficacy and safety of PMV in an elderly population.

Summary:

  • A retrospective study of 137 patients (over 50 years old) with rheumatic mitral stenosis undergoing PMV.
  • Immediate success was achieved in 93% of cases, with significant improvements in Mitral Valvular Area (MVA) and transmitral gradient.
  • Complications occurred in 13.8%, with stroke and tamponade each at 2.2%. Long-term follow-up (70 months) revealed a 19% restenosis rate.

Impact:

  • PMV with the Inoue balloon is a high-yield, acceptable-risk procedure for elderly patients with mitral stenosis.
  • The findings support PMV as a viable option for older adults, despite a notable restenosis rate.
  • This study provides crucial data for risk stratification and patient selection in this demographic.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...